🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lymphoma, T Cell, Peripheral

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas NCT06176690Phase 12 sites📍 Houston📍 Houston Baylor College of Medicine · Tests: C7R.CD30.CAR-EBVST cells Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography GVM±R in Patients With Relapsed or Refractory Aggressive NHL. NCT06244368Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: GVM±R regimen Transplantation After Complete Response In Patients With T-cell Lymphoma NCT05444712NA48 sites📍 Amiens📍 Angers📍 Argenteuil Hospices Civils de Lyon · Tests: Chemotherapy + follow up, Chemotherapy + ASCT + follow up A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide. NCT05967949n/a1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: chidamide MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma NCT07356245Phase 21 site📍 Columbus Jonathan Brammer · Tests: Ruxolitinib, Positron emission tomography-computed tomography, Bone Marrow Biopsy, Biopsy Procedure, Biospecimen Collec… A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL NCT06855823Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Golicitinib combined with Pomadomide Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma NCT06151106Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Chidamide combined with Duvillisib Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma NCT07730515Phase 1, Phase 21 site📍 Shanghai Evopoint Biosciences Inc. · Tests: XNW5004 combined with CHOP (incremental), XNW5004 combined with CHOEP (incremental), XNW5004 combined with CHOP (extend… Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma NCT04803201Phase 296 sites📍 Little Rock📍 Duarte📍 La Jolla Alliance for Clinical Trials in Oncology · Tests: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Etoposide CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma NCT04083495Phase 22 sites📍 Chapel Hill📍 Winston-Salem UNC Lineberger Comprehensive Cancer Center · Tests: ATLCAR.CD30 T cells, Bendamustine, Fludarabine, Cyclophosphamide Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma NCT07300514Phase 31 site📍 Shanghai Fudan University · Tests: PET-CTandct- DNAdetection, golidocitinib, Placebo Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) NCT06810778Phase 1, Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Duvelisib, Venetoclax A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL NCT05931263Phase 31 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: C-BEAM Regimen, BEAM Regimen Evaluate the Safety and Clinical Activity of HH2853 NCT04390737Phase 1, Phase 225 sites📍 Phoenix📍 Jacksonville📍 Rochester Haihe Biopharma Co., Ltd. · Tests: HH2853 Tablets Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection NCT07555431Phase 21 site📍 Salvador Carlos Brites · Tests: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy NCT07414758Phase 31 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: golidocitinib, Placebo A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19) NCT07234162Phase 351 sites📍 Hefei📍 Hefei📍 Beijing Dizal Pharmaceuticals · Tests: Golidocitinib, Chidamide, Gemcitabine Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL) NCT05833724Phase 26 sites📍 Kaohsiung City📍 Kaohsiung City📍 New Taipei City Great Novel Therapeutics Biotech & Medicals Corporation · Tests: Chidamide A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma NCT07075328Phase 1, Phase 25 sites📍 Fukuoka📍 Sapporo📍 Kagoshima Otsuka Medical Devices Co., Ltd. Japan · Tests: Drug:5-ALA, Device:Photodynamic system DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Alectinib Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL) NCT05976997Phase 21 site📍 Wuhan Liling Zhang · Tests: Duvelisib, Chidamide A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma NCT04045470NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Microdevices, Standard of care therapy, Standard of care systemic therapy Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma NCT06909877Phase 1, Phase 21 site📍 Chengdu Haihe Biopharma Co., Ltd. · Tests: HH2853 Tablets Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma NCT07388563Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: azacitidine, abatacept Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma NCT06519526Phase 21 site📍 Shanghai Fudan University · Tests: SHR-0302, SHR-2554 Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma NCT06160843Phase 21 site📍 Singapore National Cancer Centre, Singapore · Tests: Pembrolizumab IV infusion Q3W, with daily oral Olaparib. An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma. NCT07598578EARLY Phase 11 site📍 Suzhou Second Affiliated Hospital of Soochow University · Tests: Azacitidine (AZA) T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR NCT07353840n/a1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Autologous Hematopoietic Stem Cell Transplantation, Observation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy